Overview
- Cerebras, which filed updated terms Monday, set a $150 to $160 range on 30 million shares that could raise up to $4.8 billion.
- Investor orders topped the shares on offer by more than 20 times, according to people familiar with the bookbuilding cited in multiple reports.
- At the top of the range, the deal implies a roughly $49 billion fully diluted value, with trading planned on Nasdaq under the ticker CBRS.
- Dealogic ranks the offering as the largest IPO worldwide so far in 2026, with Morgan Stanley, Citigroup, Barclays, and UBS leading the syndicate.
- The company touts wafer‑scale processors built for inference, and its outlook is bolstered by multi‑year commitments from OpenAI and AWS after clearing a 2024 CFIUS review tied to UAE firm G42.